Thanks for choosing mmm-online.com Sign up for your FREE account now and join the thousands of other healthcare marketing professionals who rely on us for all the latest industry news and innovative ideas for direct and digital strategy. Simply fill out the fields below.

Keep me logged in Forgot your password?

Please wait...

Please wait...

In Focus Articles

Social media's strengths as source of info

May 01, 2012

FDA issues may deter drugmakers from engaging in social media, but that's no excuse to ignore what audiences are saying on these platforms
 

A shot over pharma's bow on co-pay cards

April 01, 2012

Community Catalyst has declared war on prescription co-pay cards and coupons, calling the sales tools nothing more than kickbacks and bribes.
 

Komen Foundation nurses damaged brand

March 01, 2012

Why the Susan G. Komen for the Cure Foundation's previously unassailable brand in healthcare fundraising may have sustained some permanent damage.
 

The factors behind WebMD's sale attempt

February 01, 2012

News of WebMD's planned sale—since aborted—surprised many observers.
 

Since Vioxx, hard times for pharma R&D

January 01, 2012

Everyone in biopharma knows that manufacturers are spending more to develop drugs that earn less than they did ten years ago, but a new study has put some eye-popping numbers on the industry's dwindling returns.
 

Despite ad push, HPV vax awareness flags

December 01, 2011

A little over half of US girls ages 13 to 17 have not gotten even one dose of the HPV vaccine
 

Companies react to Facebook's open walls

November 01, 2011

After Facebook's decision on August 15 to enforce open walls on the site's pharma pages, companies had two options: close down their pages altogether, or let the public openly comment on their products.
 

Why KOLs are up on Eliquis bloodthinner

October 01, 2011

Oral anticoagulant Eliquis (apixaban) has demonstrated superior efficacy and bleeding profile to standard warfarin therapy. Barring any bombshells, that should be enough for this agent, being developed by Pfizer and Bristol-Myers Squibb, to get US approval and form a compelling sales narrative in the warfarin-alternative market, analysts say.
 

FDA says device process should remain

August 15, 2011

The FDA is moving cautiously on a call by the Institute of Medicine (IOM) to scrap the approvals process for many medical devices.
 

App guidance puts pharma out of focus

July 15, 2011

FDA issued draft guidance on mobile medical apps, focusing narrowly on those programs that augment regulated medical devices or turn mobile devices into medical devices.
 
« Previous
Next »
  

Web Exclusive

Angelina Jolie's fearless but flawed message

Paul Oestreicher, Ph.D. May 17, 2013

Angelina Jolie's story raises important questions about education, outreach and access—but her nod to holistic treatments is less helpful
 

Podcasts

How to engage even the busiest physicians

March 04, 2013

Sponsored by TRUE Health + Wellness. The increasingly demanding schedules of healthcare professionals continue to narrow the window of opportunity for pharma sales teams, and, as a result, marketers are focusing more on non-personal promotion. However, there's a lot more to it than simply bombarding physicians with brand messages, as Anne Stroup, Managing Director at TRUE Health + Wellness, explains to MM&M's James Chase in this special podcast presentation.
 

2013 Hall of Fame Inductees

An entertaining look at the extraordinary lives and careers of the Medical Advertising Hall of Fame's 2013 inductees: Peter Frishauf, Dorothy Philips and David Labson. Clips produced by JUICE Pharma. 

Slideshows

MAHF 2013: Honors Class

A gallery of images from the 2013 Medical Advertising Hall of Fame induction dinner
 
Popular Topics
Acquisition Adherence Advertising App Centers For Disease Control Clinical Trial Consumer COPD Diabetes DTC Elan FDA Generic Generic Drugs iPad Lymphoma Marketing & Communications Merck Mobile Obesity Oncology Patent Cliff Patient Advocacy Patients Regulatory